Brief: Recro Pharma Announces Pricing Of $30.0 Million Public Offering Of Common Stock
May 12 (Reuters) - Recro Pharma Inc REPH.O :
* RECRO ANNOUNCES PRICING OF $30.0 MILLION PUBLIC OFFERING
OF
COMMON STOCK
* RECRO PHARMA INC - PRICING OF ITS PUBLIC OFFERING OF 13.33
MILLION SHARES AT A PRICE TO PUBLIC OF $2.25 PER SHARE
Source text for Eikon: ID:nGNX89XC2p
Further company coverage: REPH.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview